GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » Shiller PE Ratio

CDMOP.PFD (Avid Bioservices) Shiller PE Ratio : (As of May. 06, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avid Bioservices Shiller PE Ratio Historical Data

The historical data trend for Avid Bioservices's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Shiller PE Ratio Chart

Avid Bioservices Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avid Bioservices Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avid Bioservices's Shiller PE Ratio

For the Biotechnology subindustry, Avid Bioservices's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Shiller PE Ratio falls into.


;
;

Avid Bioservices Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Avid Bioservices's E10 for the quarter that ended in Oct. 2024 is calculated as:

For example, Avid Bioservices's adjusted earnings per share data for the three months ended in Oct. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Oct. 2024 (Change)*Current CPI (Oct. 2024)
=0/133.1820*133.1820
=0.000

Current CPI (Oct. 2024) = 133.1820.

Avid Bioservices Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201501 0.000 98.604 0.000
201504 0.000 99.824 0.000
201507 0.000 100.691 0.000
201510 0.000 100.346 0.000
201601 0.000 99.957 0.000
201604 0.000 100.947 0.000
201607 0.000 101.524 0.000
201610 0.000 101.988 0.000
201701 0.000 102.456 0.000
201704 0.000 103.167 0.000
201707 0.000 103.278 0.000
201710 0.000 104.070 0.000
201801 0.000 104.578 0.000
201804 0.000 105.708 0.000
201807 0.000 106.324 0.000
201810 0.000 106.695 0.000
201901 0.000 106.200 0.000
201904 0.000 107.818 0.000
201907 0.000 108.250 0.000
201910 0.000 108.577 0.000
202001 0.000 108.841 0.000
202004 0.000 108.173 0.000
202007 0.000 109.318 0.000
202010 0.000 109.861 0.000
202101 0.000 110.364 0.000
202104 0.000 112.673 0.000
202107 0.000 115.183 0.000
202110 0.000 116.696 0.000
202201 0.000 118.619 0.000
202204 0.000 121.978 0.000
202207 0.000 125.002 0.000
202210 0.000 125.734 0.000
202301 0.000 126.223 0.000
202304 0.000 127.992 0.000
202307 0.000 128.974 0.000
202310 0.000 129.810 0.000
202401 0.000 130.124 0.000
202404 0.000 132.289 0.000
202407 0.000 132.708 0.000
202410 0.000 133.182 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avid Bioservices  (NAS:CDMOP.PFD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Avid Bioservices Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices Business Description

Traded in Other Exchanges
N/A
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.